Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Mir Imran, Prominent Healthcare Investor and Entrepreneur, to Speak at SEMDA 2013 Conference


Print article Print article
© Marketwire 2013
2013-02-06 01:04:21 -

ATLANTA, GA -- (Marketwire) -- 02/05/13 -- Mir Imran, a renowned healthcare investor and entrepreneur, will speak at the SEMDA 2013 Conference prior to leading a panel discussion with a group of distinguished and diverse investors.



The seventh annual SEMDA Conference will be held on February 19-20, 2013, at the Georgia Tech Global Learning Center. Information and registration is available at www.semda.net/conference : ctt.marketwire.com/?release=982500&id=2577796&type=1& .. . The Investor Panel will be on Wednesday, February 20th, beginning at 8:30 AM.





The participants on the panel represent a wide range of investment options, ranging from traditional VC to the new trend in crowd funding, and include:



  • Opening Remarks - Mir Imran, Chairman and CEO, InCube Labs

  • Moderator - Bob Crutchfield, Harbert Venture Partners

  • Venture Capital - Mike Sherman, Partner, MB Venture Partners

  • Private Equity - John Huntz, Executive Director, Arcapita

  • Angel Investor - Dick Reeves, CEO, Angel Investor Management Group

  • Crowd Funding - Jonathan Wilson, Taylor English Duma




Imran is the Chairman and CEO of InCube Labs, which he founded to focus on his passion: creating medical solutions that change the standard of care in key healthcare markets. After attending medical school, Mir began his career as a healthcare entrepreneur in the late 1970s and has founded more than 20 life sciences companies since those early days. Over the decades, he has become one of the leading inventors and entrepreneurs in the field.



Imran now holds more than 200 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. In addition to leading InCube Labs, he also runs a life sciences venture fund, InCube Ventures, and Modulus, a medical manufacturing company.



Other stellar speakers for the SEMDA 2013 Conference include:



  • Jon Ellenthal, President, TEDMED

  • Pat Mackin, SVP & President of the Cardiac Rhythm Disease Management Division, Medtronic Corporation

  • Mark Leahey, President & CEO Medical Device Manufacturers Association (MDMA)

  • Jeffrey Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health




To register or learn more about the conference, visit www.semda.net : ctt.marketwire.com/?release=982500&id=2577799&type=1& .. or contact admin@semda.net : mailto:admin@semda.net .



About SEMDA
The Southeastern Medical Device Association (SEMDA) is a non-profit trade association that supports and promotes medical device companies in the Southeast. Created in 2004, the association provides a unique resource and networking opportunity for medical device companies, inventors, physicians, and investors interested in accelerating the growth of the medical device industry in the Southeast. Learn more at www.semda.net : ctt.marketwire.com/?release=982500&id=2577802&type=1& .. .



Add to Digg : digg.com/submit?phase=2&url= www2.marketwire.com/mw/release_html_b1?release_id=982500 Bookmark with del.icio.us : del.icio.us/post?v=4&noui&jump=close&url= www2.marketwire.com/mw/release_html_b1?release_id=982500 Add to Newsvine : www.newsvine.com/_tools/seed&save?u= www2.marketwire.com/mw/release_html_b1?release_id=982500




Media Contact:
Lynn Hood
Crackerjack Marketing
678-974-2623
Email Contact : www2.marketwire.com/mw/emailprcntct?id=E9E5B17CCF174769



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com